Search Results - "PYNKA, M"

Long‐term trends in HIV care entry: over 15 years of clinical experience from Poland by Siwak, E, Horban, A, Witak‐Jędra, M, Cielniak, I, Firląg‐Burkacka, E, Leszczyszyn‐Pynka, M, Witor, A, Muller, K, Bociąga‐Jasik, M, Kalinowska‐Nowak, A, Gąsiorowski, J, Szetela, B, Jabłonowska, E, Wójcik‐Cichy, K, Jankowska, J, Lemańska, M, Olczak, A, Grąbczewska, E, Grzeszczuk, A, Rogalska‐Plonska, M, Suchacz, M, Mikuła, T, Łojewski, W, Bielec, D, Kocbach, P, Błudzin, W, Parczewski, M

“…Introduction Delay in HIV diagnosis and consequently late care entry with low CD4 counts remain a major challenge for the control of the HIV/AIDS epidemic. The…”
Get full text

Association of chemokine receptor gene variants with HIV‐1 genotype predicted tropism by Parczewski, M, Urbańska, A, Maciejewska, K, Clark, J, Leszczyszyn‐Pynka, M

“…Objectives As a switch from chemokine (C‐C motif) receptor 5 [CCR5 (R5)] to chemokine (C‐X‐C motif) receptor 4 [CXCR4 (X4)] HIV‐1 tropism is associated with…”
Get full text

Introduction of pharmacogenetic screening for the human leucocyte antigen (HLA) B5701 variant in Polish HIV‐infected patients by Parczewski, M, Leszczyszyn‐Pynka, M, Wnuk, A, Urbañska, A, Fuksiñska, K, Bander, D, Boroñ‐Kaczmarska, A

“…Objective Prospective pharmacogenetic screening for the human leucocyte antigen (HLA) B*5701 allele can significantly reduce the number of cases of…”
Get full text

Integrase resistance variants among integrase inhibitor treatment‐naïve and treated patients from Northwestern Poland by Parczewski, M, Leszczyszyn‐Pynka, M, Urbanska, A, Bander, D, Boron‐Kaczmarska, A

“…Purpose of the study HIV integrase inhibitor use is limited by low genetic barrier to resistance and possible cross‐resistance among representatives of the…”
Get full text

CCR5 D32 modifies 15‐year mortality risk associated with well‐established clinical and immunological factors among HIV‐infected patients by Parczewski, M, Leszczyszyn‐Pynka, M, Bander, D, Urbañska, A, Kaczmarczyk, M, Ciechanowicz, S, Boron‐Kaczmarska, A

“…7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK…”
Get full text

Sequence variants of chemokine receptor genes and susceptibility to HIV-1 infection by Parczewski, M., Leszczyszyn-Pynka, M., Kaczmarczyk, M., Adler, G., Bińczak-Kuleta, A., Łoniewska, B., Boroń-Kaczmarska, A., Ciechanowicz, A.

“…Genetic susceptibility to HIV infection was previously proven to be influenced by some chemokine receptor polymorphisms clustering on chromosome 3p21. Here the…”
Get full text

Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002 by Podlasin, R B, Wiercinska-Drapalo, A, Olczak, A, Beniowski, M, Smiatacz, T, Malolepsza, E, Juszczyk, J, Leszczyszyn-Pynka, M, Mach, T, Mian, M, Knysz, B, Horban, A

“…The introduction of highly active antiretroviral therapy (HAART) led to a decreased incidence of the most severe opportunistic infections (OIs) in HIV-infected…”
Get full text

HIV-1 drug resistance patterns among treatment-naïve and therapy-experienced patients in Poland by Stańczak, G.P, Stańczak, J.J, Majchrzak, M.J, Burkacka, E, Wiercińska-Drapało, A, Leszczyszyn-Pynka, M, Jabłonowska, E, Małolepsza, E, Horban, A

“…Summary Background HIV-1 drug resistance (DR) is becoming a growing concern. It is estimated that about one out of ten newly HIV-infected persons in Europe…”
Get full text

Infection‐related and ‐unrelated malignancies, HIV and the aging population by Borges, ÁH, Ledergerber, B, Domingo, P, Knysz, B, Karpov, I, Kirk, O, Lundgren, J, Clumeck, N., Vandekerckhove, L., Machala, L., Kronborg, G., Larsen, M., Gerstoft, J., Katzenstein, T., Skinhøj, P., Pedersen, C., Dragsted, U. B., Zilmer, K., Girard, P‐M., Vanhems, P., Pradier, C., Neau, D., Schmidt, R., Lunzen, J., Stellbrink, H. J., Bickel, M., Fätkenheuer, G., Kosmidis, J., Gargalianos, P., Perdios, J., Gottfredsson, M., Burke, M., Pollack, S., Hassoun, G., Haouzi, M., Esposito, R., Arici, C., Pristera, R., Mazzotta, F., Montesarchio, E., Gargiulo, M., D'Offizi, G., Taibi, C., Antinori, A., Lazzarin, A., Ridolfo, A., Chaplinskas, S., Reiss, P., Ormaasen, V., Boron‐Kaczmarska, A., Pynka, M., Parczewski, M., Mularska, E., Jablonowska, E., Wojcik, K., Doroana, M., Caldeira, L., Maltez, F., Duiculescu, D., Rakhmanova, A., Buzunova, S., Jevtovic, D., Mokráš, M., Staneková, D., Rodriguez, J. M., Bravo, I., Gatell, J. M., Medrano, J., Flamholc, L., Weber, R., Francioli, P., Cavassini, M., Boffi, E., Battegay, M., Elzi, L., Kravchenko, E., Frolov, V., Kutsyna, G., Servitskiy, S., Kuznetsova, A., Kyselyova, G., Simons, E., Orkin, C., Fisher, M., Horban, A., Pedersen, C., Rakhmanova, A., Phillips, A., Cozzi‐Lepri, A., Grint, D., Schultze, A., Raben, D., Kjær, J., Fischer, A. H., Grarup, J., Thiebaut, R., Burger, D., Paredes, R., Kjær, J., Peters, L.

“…Objectives HIV‐positive people have increased risk of infection‐related malignancies (IRMs) and infection‐unrelated malignancies (IURMs). The aim of the study…”
Get full text

Disseminated infection with Saccharomyces kluyveri in a patient with AIDS by PYNKA, M, WNUK, A, BANDER, D, SYCZEWSKA, M, BORON, A, PROST, B, WRZECION, S

“…A 47-year-old man with acquired immune deficiency syndrome was found to have disseminated Saccharomyces kluyveri infection. The yeast was isolated from blood…”
Get full text

Disseminated infection withSaccharomyces kluyveri in a patient with AIDS by Pynka, M., Wnuk, A., Bander, D., Syczewska, M., Boroń, A., Prost, B., Wrzecion, S.

“…A 47-year-old man with acquired immune deficiency syndrome was found to have disseminatedSaccharomyces kluyveri infection. The yeast was isolated from blood…”
Get full text

Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study by Reekie, Joanne, Kowalska, Justyna D, Karpov, Igor, Rockstroh, Jurgen, Karlsson, Anders, Rakhmanova, Aza, Horban, Andrzej, Kirk, Ole, Lundgren, Jens D, Mocroft, Amanda

“…Differences in access to care and treatment have been reported in Eastern Europe, a region with one of the fastest growing HIV epidemics, compared to the rest…”
Get full text

IL28B CC genotype is associated with higher all-cause mortality in antiretroviral-treated HIV-infected patients by Parczewski, Miłosz, Bander, Dorota, Leszczyszyn-Pynka, Magdalena, Urbańska, Anna, Socha, Łukasz, Boroń-Kaczmarska, Anna

“…Il28B single nucleotide polymorphisms were found to influence interferon λ expression, resulting in changes in hepatitis C virus (HCV)-RNA serum levels as well…”
Get more information

Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study by Florence, E, Lundgren, J, Dreezen, C, Fisher, M, Kirk, O, Blaxhult, A, Panos, G, Katlama, C, Vella, S, Phillips, A

“…Objectives To describe the prevalence and risk factors of poor CD4 count rise despite a good virological response on highly active antiretroviral treatment…”
Get full text

Thymidine analogue mutation profiles : factors associated with acquiring specific profiles and their impact on the virological response to therapy by COZZI-LEPRI, Alessandro, RUIZ, Lidia, LOVEDAY, Clive, PHILLIPS, Andrew N, CLOTET, Bonaventura, REISS, Peter, LEDERGERBER, Bruno, HOLKMANN, Christian, STASZEWSKI, Schlomo, LUNDGREN, Jens D

“…Studies have suggested that HIV-1 may develop thymidine analogue mutations (TAMs) by one of two distinct pathways - the TAM1 pathway (including mutations 41L,…”
Get full text

Changes in hospital admissions across Europe: 1995–2003. Results from the EuroSIDA study by Mocroft, A, D'Arminio Monforte, A, Kirk, O, Johnson, MA, Friis‐Moller, N, Banhegyi, D, Blaxhult, A, Mulcahy, F, Gatell, JM, Lundgren, JD

“…Objectives To describe changes in the proportions of patients admitted to hospital and the duration of admission during the month of March between 1995 and…”
Get full text

Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection? by MOCROFT, Amanda, ROCKSTROH, Jurgen, SORIANO, Vincent, LEDERGERBER, Bruno, KIRK, Ole, VINOGRADOVA, Elena, REISS, Peter, KATLAMA, Christine, PHILLIPS, Andrew N, LUNDGREN, Jens D

“…Liver damage associated with hepatitis C (HCV) may influence the likelihood of experiencing discontinuation due to toxicities or patient/physician choice…”
Get full text

Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study by MOCROFT, A, PHILLIPS, A. N, FRIIS-MØLLER, N, COLEBUNDERS, R, JOHNSON, A. M, HIRSCHEL, B, SAINT-MARC, T, STAUB, T, CLOTET, B, LUNDGREN, J. D

“…There is an increasing proportion of HIV-positive patients exposed to all licensed classes of antiretrovirals, and the response to salvage regimens may be…”
Get full text

Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study by CABRERA, Cecilia, COZZI-LEPRI, Alessandro, CLOTET, Bonaventura, RUIZ, Lidia, PHILLIPS, Andrew N, LOVEDAY, Clive, KIRK, Ole, AITKHALED, Mounir, REISS, Peter, KJOER, Jesper, LEDERGERBER, Bruno, LUNDGREN, Jens D

“…To investigate the ability of several HIV-1 drug-resistance interpretation systems, as well as the number of pre-specified combinations of abacavir-related…”
Get full text

Natural cytotoxicity of peripheral blood mononuclear cells in Herpes simplex and Varicella-zoster virus infections by Leszczyszyn-Pynka, M

“…Natural cytotoxicity of peripheral blood was assessed in adults with recurrent Herpes labialis and in patients with Herpes zoster. CD16+ cells count,…”
Get more information